The *next* 10x GLP-1 stock won't be the drug. It will be the stock that *supplies* it.
The Trillion-Dollar Winner
LLY is a fantastic stock. But as a $1T+ company, its days of 10x growth are over. The demand it created, however, is the new "gold rush".
Lilly and Novo are completely sold out. Their biggest problem isn't marketing; it's manufacturing.
They are desperate for specialized vials and auto-injectors. The stocks that supply these are the *new* explosive plays.
We found one small-cap *stock* that just signed a $500M contract to supply injector components. This stock is still under the radar.
Add to Get the 'Supplier' Stock